Australia markets closed

Novartis AG (NVS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
86.75+0.14 (+0.16%)
At close: 4:00PM EDT

87.00 +0.25 (0.29%)
Pre-market: 8:11AM EDT

Full screen
Trade prices are not sourced from all markets
Previous close86.61
Open86.46
Bid86.89 x 800
Ask86.76 x 1000
Day's range86.46 - 86.89
52-week range77.04 - 98.52
Volume1,695,049
Avg. volume2,006,583
Market cap195.872B
Beta (5Y monthly)0.51
PE ratio (TTM)24.64
EPS (TTM)3.52
Earnings dateN/A
Forward dividend & yield3.20 (3.69%)
Ex-dividend date04 Mar 2021
1y target est104.67
  • 5 Megacap Stocks With 19% to 32% Upside, According to Wall Street
    Motley Fool

    5 Megacap Stocks With 19% to 32% Upside, According to Wall Street

    According to Wall Street, the following five megacap stocks -- i.e., publicly traded companies with a market cap of at least $200 billion -- offer upside over the next 12 months ranging from 19% to as much as 32%. Is anyone really all that surprised that e-commerce giant Amazon (NASDAQ: AMZN) is on this list?

  • Novartis (NVS) Teams Up With Artios for Radioligand Therapies
    Zacks

    Novartis (NVS) Teams Up With Artios for Radioligand Therapies

    Novartis (NVS) enters a three-year collaboration with Artios to strengthen its radiogland therapies pipeline.

  • Financial Times

    Roche/Novartis: rivals play king of the pill

    No surprise then that neighbours Roche and Novartis — both run out of Basel, Switzerland — want to occupy the same ground. For years, differing strategies kept the two pharmaceutical companies apart. Roche was a “pure play” pharma company while Novartis was diversified.